Short answer
Baxter International (BAX) filed an 8-K current report with the SEC on August 19, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). John Rogers appointed CFO effective October 1, 2026, following leadership roles at Smith+Nephew and WPP.
Baxter International 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- John Rogers appointed CFO effective October 1, 2026, following leadership roles at Smith+Nephew and WPP
- CFO compensation includes $925,000 salary, 100% target bonus, and $4,000,000 annual equity target
- Two off-cycle equity grants include target values of $3,861,494 and a prorated $4,000,000 award
- Anita Zielinski departs September 15, 2026, with CEO Andrew Hider serving as interim CFO for two weeks without added compensation
- Bernie Heine becomes interim CAO and Controller, receiving $15,000 monthly and a $250,000 restricted-stock-unit award
Item 7.01 · Regulation FD Disclosure
- Reg FD disclosure consists solely of standard safe-harbor language
- No operating, financial, strategic, or shareholder-relevant information disclosed
Item EX-99.1 · Exhibit EX-99.1
- John Rogers appointed CFO effective October 1, 2026, replacing the current finance leadership
- Medtech finance executive brings transformation experience from Smith+Nephew and WPP
- Appointment supports Baxter’s turnaround, balance-sheet strengthening and financial-discipline priorities
- Full-year 2026 financial outlook reiterated from July 30 earnings announcement
- Leadership transition introduces execution risk while Baxter pursues sustainable value creation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Baxter International 8-K filings
Get the next BAX 8-K as it lands
Follow BAX for push alerts, or ask the research agent what this filing means.